Clinical Trials Logo

Psychosis clinical trials

View clinical trials related to Psychosis.

Filter by:

NCT ID: NCT05670197 Recruiting - Schizophrenia Clinical Trials

Service User and Staff Views on Digital Remote Monitoring for Psychosis

Start date: November 1, 2022
Phase:
Study type: Observational

Psychosis is a severe mental health problem. Symptoms of psychosis include hallucinations (e.g. hearing voices that others cannot hear) and delusions (unusual, often troubling beliefs). People who experience psychosis often have times when their symptoms are relatively stable. At other times, their symptoms may increase and become much more problematic (a 'relapse'). Helping people with psychosis to stay well (preventing relapses) is an important and time-consuming challenge for mental health services. Smartphones and other digital technologies are now widespread. This offers a solution to help tackle the overwhelming demand on services and to enable people with psychosis to access mental health support when they need it most (e.g. when relapsing). Research shows that people with psychosis are often willing to report their symptoms using a smartphone app. Apps like this can alert health professionals when someone needs extra support, but can be burdensome to use long-term. The investigators want to make a system that is less burdensome and is personalised to users' needs and experiences (a 'complex digital remote monitoring system'). Recent research shows that information gathered routinely by individuals' smartphones (e.g. GPS, step count) might help predict relapses of psychosis. The investigators want to use this method in a complex digital remote monitoring system. First, the investigators need to know what people with psychosis and mental health staff think about this idea. The investigators will interview around sixty adults with psychosis and around forty staff, recruited from UK mental health services (Manchester, Glasgow, Edinburgh, Cardiff, London, Sussex). These one-off, audio-recorded interviews will last up to 60 minutes. The interviewer will ask about participants' views on complex digital remote monitoring. The investigators will then systematically analyse the interviews. Findings will inform the design of the investigators' own complex digital remote monitoring system and future digital tools designed by other researchers. NIHR and Wellcome are funding this study.

NCT ID: NCT05664594 Recruiting - Schizophrenia Clinical Trials

State Representation in Early Psychosis - Project 4

STEP (P4)
Start date: July 31, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to examine state representation in individuals aged 15-45 who have been diagnosed with a psychotic illness, as well as young adults who do not have a psychiatric diagnosis. State Representation is our ability to process information about our surroundings. The investigators will complete a clinical trial examining two paradigms of cognitive training.

NCT ID: NCT05619822 Enrolling by invitation - Psychosis Clinical Trials

A Comprehensive Third-generation Intervention for People With Psychosis and Post-traumatic Stress Symptoms

IITG-PPT
Start date: May 27, 2022
Phase: N/A
Study type: Interventional

Existing data suggest that both trauma and Post-Traumatic Stress Disorder (PTSD) are very common among individuals with psychosis. The presence of PTSD symptoms in psychosis is associated with worse clinical outcomes and poorer social functioning. However, PTSD is a poorly attended and poorly studied condition among this population. Research to date indicates that trauma-focused treatments are safe and effective for PTSD, even when psychotic comorbidity is present. Recent systematic reviews of psychological interventions for trauma in psychosis found that are effective in reducing trauma symptoms, suggesting that they should be implemented in front-line services. Nonetheless, larger confirmative trials are required to form robust conclusions.The aim of this project is to examine the efficacy of comprehensive third-generation protocol for people with comorbid trauma and psychosis.

NCT ID: NCT05617898 Recruiting - Psychosis Clinical Trials

Determining the Role of Social Reward Learning in Social Anhedonia

SAMI
Start date: June 14, 2023
Phase: N/A
Study type: Interventional

This is a clinical trial study that aims to evaluate the specificity of the relationship between reduced sensitivity to social reward and social anhedonia at both behavioral and neural levels. Individuals who recently experienced their first-episode psychosis will be recruited. Participants will be randomized 1:1 to motivational interviewing or a time- and format-matched control probe. At pre- and post-probe, participants will perform two social reward learning tasks in the scanner. With this design feature, we will examine the relationship between sensitivity to social reward and reduced subjective experience of social pleasure at both the behavioral and neural levels.

NCT ID: NCT05603260 Completed - Psychosis Clinical Trials

Imagery Interventions for Auditory Vocal Hallucinations

Start date: April 7, 2022
Phase: N/A
Study type: Interventional

This study explores the feasibility, acceptability, and effectiveness of four imagery intervention techniques (metacognitive imagery intervention, imagery rescripting, promoting positive imagery and competing imagery task) for auditory vocal hallucinations using four single case series with an A-B-A within subject design.

NCT ID: NCT05584215 Withdrawn - Psychosis Clinical Trials

Cognitive Behavioural Therapy-Informed Groups for Psychosis

CBTp
Start date: June 3, 2023
Phase: N/A
Study type: Interventional

This is a feasibility study of cognitive behavioural therapy-informed groups for psychiatric inpatients with positive symptoms of psychosis.

NCT ID: NCT05571228 Active, not recruiting - Schizophrenia Clinical Trials

Be Outspoken and Overcome Stigmatizing Thoughts (BOOST) Group for Early Psychosis

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

Internalized stigma, (i.e. the application of negative stereotypes about a diagnostic group to one's self) is a strong predictor of recovery and quality of life for individuals with psychosis. Be Outspoken and Overcome Stigmatizing Thoughts (BOOST) is an evidence-based intervention aimed at improving internalized stigma, self-esteem, and quality of life for those with psychosis. The proposed research expands BOOST's program by adding additional therapeutic methods and material, and adopting the use of virtual care methods to: (a) increase the generalization of treatment effects, (b) examine long-term treatment effects, and (C) provide rural Ontario communities with remote treatment access.

NCT ID: NCT05567575 Recruiting - Psychosis Clinical Trials

Cognitive Behavior Therapy (CBT) Informed Mobile-Application for First Episode Psychosis

TechCare
Start date: October 1, 2022
Phase: N/A
Study type: Interventional

Onset of First Episode Psychosis (FEP) is at a young age and is a critical period influencing the long-term course of the disorder. Failure to identify FEP can lead to serious implications such as disruption of education, reduced long-term employment, huge economic burden, and is associated with significantly higher mortality. The prevalence of psychosis increases rapidly from age 14 onwards with a peak incidence in the late teens and early 20s. The aim of the project is to examine the acceptability and feasibility of a mobile phone application-based intervention 'TechCare-PK', for individuals with psychosis in Pakistan. The main objectives are to determine whether appropriate individuals could be identified and recruited to the study and whether the TechCare App would be an acceptable intervention for individuals with psychosis.

NCT ID: NCT05558332 Not yet recruiting - Suicide Clinical Trials

Youth Nominated Support Team

YST
Start date: September 2024
Phase: N/A
Study type: Interventional

This study aims to adapt the current Youth-Nominated Support Team (YST) manual used to treat suicide risk for people at clinical high risk for psychosis.

NCT ID: NCT05538832 Recruiting - Schizophrenia Clinical Trials

Remote State Representation in Early Psychosis

Rem-STEP
Start date: July 27, 2022
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to examine state representation in individuals aged 15-40 who have been diagnosed with a psychotic illness, as well as young adults who do not have a psychiatric diagnosis. State Representation is our ability to process information about our surroundings. The investigators will complete some observational tests as well as a cognitive training clinical trial.